Cellular reprogramming research collab with Retr
Author: Michael
Lighthouse Pharmaceuticals received a $49.
Lighthouse Pharma lands major grant funding to a
Japanese XPRIZE semifinalist draws on Nobel-winn
Protagenic Therapeutics has completed first-dose
Milken Institute calls for greater investment in
DiamiR Biosciences and Aptorum Group announced th
Life Time has launched a new sleep-support produc
Clinical trials, biomarker standardization and s
Patientory has made its AI-Enterprise Analytics D